DrugPatentWatch Database Preview

Details for Patent: 10,130,592

« Back to Dashboard

Which drugs does patent 10,130,592 protect, and when does it expire?

Patent 10,130,592 protects ADRENALIN and is included in one NDA.

This patent has seven patent family members in seven countries.

Summary for Patent: 10,130,592

Title:	Epinephrine formulations
Abstract:	Pharmaceutical compositions comprising epinephrine, methods of administration, and methods of making the same. Compositions may comprise at least one of an active agent, a pH raising agent, an antioxidant, a transition metal complexing agent, a pH lowering agent, a tonicity regulating agent, optionally a preservative, and optionally a solvent.
Inventor(s):	Kannan; Vinayagam (Rochester, MI), Irish; Patrick (Sterling Heights, MI), Bergren; Michael (Henderson, NV)
Assignee:	PAR PHARMACEUTICAL, INC. (Chestnut Ridge, NY)
Application Number:	14/863,112
Patent Claim Types: see list of patent claims	Composition; Compound;

Drugs Protected by US Patent 10,130,592

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Par Sterile Products	ADRENALIN	epinephrine	SOLUTION;INTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS	204640-001	Dec 18, 2013	AP	RX	Yes	Yes			Y

International Family Members for US Patent 10,130,592

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Australia	2016233682
Canada	2978464
China	107614017
European Patent Office	3268045
Japan	2018507915